Text Version
Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM
Gateway
TOXNET
Consumer
Health
Clinical Alerts
ClinicalTrials.gov
PubMed
Central
Privacy Policy
|
 |
-
Recurrent toxic delirium in a
patient treated with SSRIs: is old age a risk
factor?
Amir I, Dano M, Joffe A.
Tel
Aviv Community Mental Health Center, Israel.
We present the case
of a 71-year-old female suffering from bipolar affective disorder type 2
and an old lacunar brain infarct who, under the combined treatment of
fluoxetine for depression and low dose trazodone for the accompanying
insomnia, developed a toxic delirium. The subject presented with mental
state changes (confusion and agitation), hyperreflexia, diaphoresis,
nausea, vomiting, fever, and a general tonic-clonic seizure which
developed soon after an increase in the trazodone dose. One year prior
to the above episode, she was hospitalized for a transient episode of
agitated confusion while being treated with fluvoxamine for depression,
alprazolam and brotazolam for the accompanying anxiety and insomnia.
Both episodes subsided spontaneously when treatment was discontinued.
This case reports the possible existence of increased vulnerability to
hyperserotonergic states in elderly patients suffering from concomitant
psychiatric and neurological disorders.
Publication Types:
PMID: 9231573 [PubMed - indexed for
MEDLINE]
|